Holen Sie sich die Stockscreener-App
2.79
2.20%
0.06
Handel nachbörslich:
2.73
-0.06
-2.15%
Finanzdaten der Revelation Biosciences Inc-Aktie (REVB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
17.48%
2.4612
|
2.095 | 1.7539 | 1.7967 | 2.5224 |
| Operating Income/Loss |
17.48%
-2.4612
|
-2.095 | -1.7539 | -1.7967 | -2.5224 |
| Nonoperating Income/Loss |
61.63%
0.0168
|
0.0439 | 0.0282 | -0.4449 | -5.8674 |
| Income/Loss From Continuing Operations Before Tax |
19.18%
-2.4444
|
-2.0511 | -1.7257 | -2.2416 | -8.3898 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
19.18%
-2.4444
|
-2.0511 | -1.7257 | -2.2416 | -8.3898 |
|
Net Income/Loss
|
19.18%
-2.4444
|
-2.0511 | -1.7257 | -2.2416 | -8.3898 |
| Preferred Stock Dividends And Other Adjustments |
3.1818
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
17.36%
0.8027
|
0.9713 | -1.6334 | 2.6799 | 1.6352 |
| Diluted Average Shares |
17.36%
0.8027
|
0.9713 | -1.6334 | 2.6799 | 1.6352 |
| Basic Earnings Per Share |
232.23%
-7.01
|
-2.11 | -80.30 | -0.84 | -5.13 |
| Diluted Earnings Per Share |
232.23%
-7.01
|
-2.11 | -80.30 | -0.84 | -5.13 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
3.1818
|
- | - | - | - |
1.33%
1.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):